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It has been recognized for decades that children
with kidney disease often do not grow normally.
Growth failure has been identified in children with
tubular disorders who have normal glomerular func-
tion and in those with renal insufficiency due to any
etiology. In the last decade, growth failure also has
been described in children undergoing chronic dial-
ysis and after renal transplantation. Thus, the po-
tential for growth impairment exists in all stages,
from the onset of renal disease to renal failure, and
through phases of treatment with dialysis and trans-
plantation. We will review the prevalence of growth
retardation during the stages of disease and treat-
ment, the patterns of growth in renal disease, and
the causes of growth failure.
Prevalence of growth retardation
The prevalence of growth retardation in children
during various stages of renal disease is shown in
Table 1. Many of the children in the first two studies
cited did not have renal insufficiency. A high per-
centage of children with renal disease have retarded
growth; this percentage does not change appre-
ciably during the progression of disease to renal fail-
ure, through treatment with dialysis and trans-
plantation.
There is little information concerning the growth
rates of children with renal insufficiency. Betts and
Magrath [1] found that the growth velocity of 15
children with renal insufficiency from infancy main-
tained stature above the third percentile (within 2.5
SD of the normal) until GFR fell below 25
mllmin/1.73 m2, at which time growth rates de-
creased. Growth rates of children undergoing dial-
ysis and after transplantation have received more
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attention. Broyer et al [2] reported that 4 of 17 chil-
dren undergoing hemodialysis for longer than 1 yr
grew at rates exceeding 80% of normal for their
bone age. European Dialysis and Transplant Asso-
ciation figures for 1975 showed that 136 of 298 chil-
dren (46%) undergoing hemodialysis and 49 of 103
(48%) after transplantation had growth rates greater
than the 3rd percentile (> 2.5 SD) [3]. In the only
report concerning children undergoing chronic pen-
toneal dialysis, 3 of 11 had growth rates maintaining
stature within 2.5 SD of the normal [4]; the growth
rates of children after transplantation are discussed
elsewhere (see Travis et a!, this issue).
Patterns of growth
The prevalence and severity of growth failure are
greater in children with congenital renal diseases
than they are in those with acquired diseases. Of the
21 children with growth retardation studied by West
and Smith [51, 17 had congenital disease and 4 had
nephritis with nephrotic syndrome. Of the 24 chil-
dren with chronic renal disease studied by
Bergstrom, De Leon, and Van Gemund [61, 59% of
those with congenital disease had growth failure,
whereas the 2 children with acquired disease had
normal height. In Stickler and Bergen's study of 64
children [7], 71% with congenital disease and 44%
with acquired disease had retarded growth. In Betts
and Magrath's report of 33 children [1], 50% with
congenital disease and 10% with acquired disease
had growth failure.
The higher prevalence of growth retardation in
children with congenital disease might be explained
by a higher incidence of tubular disorders in the
former, by a longer duration of renal disease, or by
an increased susceptibility of the rapidly growing
infant to growth failure. The association of tubular
disorders and growth impairment will be considered
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CRD[51 41 21 51 Not defined
CRD[6] 24 16 67  3rd%
CRD with BUN > 50 mg/dl [7] 64 36 56 < 3rd %
CRDwithGFR < 7Oml/min/l.73m2[1] 33 12 36 3rd%
Children at start of dialysis or
transplantation [3] 360 147 41 < 3rd%
Children at transplantation' 50 28 56 < 3rd %
Children Ito 10 yr aftertransplantation' 50 34 68 < 3rd%
Numbers in brackets denote reference source from which data was derived.
Potter, unpublished observations.
in the section "Causes of growth failure." Habib
et al [8] demonstrated that children with congenital
renal disease had a longer duration of disease before
the development of terminal renal failure than those
with acquired conditions had, but they did not exam-
ine the effects of renal disease on growth. Betts and
Magrath [I] found that many children with congeni-
tal disease had severe growth retardation in infancy
associated with exacerbations of the disease, and
that thereafter, renal function stabilized or improved
and growth proceeded at normal rates, often for
many years, until GFR fell below 25 mI/mm/I .73 m2,
when growth decreased again. The consequences of
growth retardation in infancy are profound, since
approximately one third of a child's total growth
occurs in the first 2 yr of life. This pattern of growth,
with the loss of 10 to 15 cm in the first 2 yr, may ac-
count for most of the loss of stature in children with
congenital disease who are severely retarded when
they enter dialysis and transplant programs later in
childhood.
The ultimate stature achieved by a child with
growth retardation will depend on the rate of
growth relative to the rate of skeletal maturation. In
a child with delayed skeletal maturation, the poten-
tial for further growth lies somewhere between that
predicted from chronological age and that predicted
from skeletal maturation [91. Betts and White [101
showed that in children who had retarded growth
and skeletal development during infancy, chrono-
logic age and skeletal maturation subsequently ad-
vanced in parallel. Under these circumstances, a
child growing at a normal rate for chronologic age
nevertheless has a progressive loss of growth poten-
tial. When growth temporarily ceases and skeletal
maturation continues, as occurred in three children
who developed osteodystrophy, there is an even
greater loss of growth potential. At puberty, Broyer
et al [2] noted that children with retarded growth
and skeletal development who were undergoing
chronic dialysis had rapid skeletal maturation and
fusion of epiphyses without a corresponding in-
crease in height, thus terminating growth. This pat-
tern of rapid bone maturation with the loss of one or
more years of potential growth at puberty has also
been noted by Pennisi et al [11] in children after
transplantation and by Lewy and New [12] and lim-
its the adult stature achieved by most children with
growth retardation and renal disease. On the other
hand, Lilly et al [13] reported that five growth re-
tarded children continued to grow after trans-
plantation well past the usual age of puberty and
ultimately achieved normal stature. The relation-
ship of growth to the onset and duration of puberty
and to bone maturation was not specified in their
report.
Causes of growth failure
A number of specific disorders commonly seen in
kidney disease have been associated with growth
failure. These include azotemia per se, acidosis, hy-
posthenuria, renal osteodystrophy, endocrine dys-
function, calorie deficiency, abnormalities of pro-
tein metabolism and glucocorlicoid therapy. The
potential contribution of each mechanism varies
with the type and stage of renal disease under con-
sideration. There is good evidence that the pro-
found acidosis which results from bicarbonate-
wasting in children with renal tubular acidosis
(RTA) is a cause of growth failure. Nash et al [14]
showed that eight of nine children with proximal
RTA who had otherwise normal renal function and
four children with distal RTA who had con-
centrating defects were at or below the third per-
centile for stature. Correction of the acidosis with
bicarbonate resulted in normal growth in eight chil-
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dren who were evaluated. McSherry, Sebastian,
and Morris, Jr., [15] reported catch-up growth and
normal stature in 10 children whose acid-base stat-
us was maintained at normal with alkali therapy
(see McSherry, this issue).
The contribution of the less severe acidosis re-
sulting from retention of hydrogen ions to growth
retardation in chronic renal insufficiency is less
clear. Although West and Smith [51 found that 15 of
17 children with impaired growth and azotemia
were acidotic, Stickler and Bergen [7] could find no
relationship between growth and acidosis in 16 chil-
dren with renal insufficiency. Several authors
[6, 12] have commented that treatment of the aci-
dosis of renal insufficiency with bicarbonate does
not improve growth. Chronic hemodialysis usually
corrects acidosis, but the majority of children under-
going dialysis do not grow normally.
West and Smith [5] found that impaired renal con-
servation of water was also a common factor associ-
ated with growth failure in children with renal dis-
ease although they noted several children with im-
paired concentrating ability who grew normally.
Stickler and Bergen [71 were unable to show an as-
sociation between growth and concentrating ability.
Some children with nephrogenic diabetes insipidus,
who make large quantities of dilute urine, have im-
paired growth, apparently because their constant
need for water interferes with adequate food intake
[16]. Children with other tubular disorders and
those with renal insufficiency often excrete moder-
ately increased amounts of isotonic urine, but the
need to replace these losses does not preclude nor-
mal food intake. Since failure to concentrate urine
is a common finding in children with renal in-
sufficiency, its association with growth retardation
in some children is not surprising and does not im-
ply a cause and effect relationship.
Osteodystrophy, especially rickets, is known to
interfere with growth. In children with the Fanconi
syndrome and other tubular disorders, osteo-
dystrophy has been considered to be a consequence
of renal phosphate loss although some investigators
have implicated impaired renal metabolism of vita-
min D [17, 18]. In renal failure, impaired metab-
olism of vitamin D and retention of phosphorus,
leading to hyperphosphatemia, hypocalcemia, and
secondary hyperparathyroidism, contribute to os-
teodystrophy. In children with rickets and growth
retardation, treatment with vitamin D or its metabo-
lites restores growth to normal [19], whereas in two
children with secondary hyperparathyroidism,
Broyer et al [21 reported a dramatic growth spurt
following parathyroidectomy. The suggestion by
Stickler and Bergen [7], that subtle changes in cal-
cium and phosphorus metabolism which are not ac-
companied by overt osteodystrophy cause growth
retardation in children, has not been adequately
tested (see also Avioli, this issue).
The role of endocrine factors in the growth retar-
dation of renal disease is unclear. Growth hormone
levels are normal or elevated in children with renal
faiure [20, 21]. Somatomedin, which mediates the
effect of growth hormone on cartilage, has been re-
ported to be low in growth retarded children with
renal insufficiency [22, 23] and in children under-
going dialysis [24]. In the children studied by Saen-
ger et a! [22], somatomedin activity increased into
the normal range after transplantation and corre-
lated with linear growth, although four patients with
normal somatomedin levels continued to grow at
subnormal rates. Somatomedin activity was mea-
sured by bioassay in these studies. Schwalbe et al
[23] demonstrated a highly significant correlation
between somatomedin activity and growth velocity
in uremic children and a correlation between soma-
tomedin activity and GFR. In six of seven patients,
Pennisi et a! [24] showed that somatomedin levels
increased after dialysis and that postdialysis levels
correlated with growth. Using a radioreceptor as-
say, however, Arnold et a! [25] found that soma-
tomedin levels were normal in children with mild
renal insufficiency, elevated in those with more se-
vere renal insufficiency, and highest in children on
chronic dialysis. There was a correlation between
somatomedin levels and growth in the children with
severe renal insufficiency. It has been suggested
[22] that there is an inhibitor of the bioassay in ure-
mic serum which would account for some of the dis-
crepancies in published results. Somatomedin lev-
els have also been reported to be low in children
with protein calorie malnutrition [261 (see also
Lewy and VanWyk, this issue).
Most investigators have discounted the impor-
tance of azotemia itself in the etiology of growth
failure. West and Smith [5] found that 16 of the 21
children with growth retardation had azotemia
(blood urea nitrogen levels> 20 mg/dl or nonprotein
nitrogen levels> 40 mg/dl) but 2 children with simi-
lar levels grew normally. Only 6 of 16 children with
growth retardation studied by Bergstrom et al [6]
had azotemia. Stickler and Bergen [7], could find no
association between growth and serum urea levels.
Betts and Magrath [1] noted impaired growth in chil-
dren whose GFRs decreased to less than 25 mI/minim2.
There is some correlation, however, between high
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concentrations of blood urea nitrogen and toxic ure-
mic symptoms; nitrogenous metabolites may inter-
fere with growth by causing anorexia or by inter-
fering with protein metabolism, either directly or
through action on hormonal systems (see also Hol-
liday and Chantler, this issue).
Malnutrition and abnormalities of protein metabolism
A large body of work has accumulated which sug-
gests that malnutrition, primarily calorie malnutri-
tion, is a cause of growth failure in children with
renal disease. West and Smith 115], using a weight-
for-height index of less than 0.95 as an indicator of
poor calorie intake, found that 8 of 16 nonedema-
tous children with growth retardation had indices
below this level and concluded that calorie malnu-
trition was an important factor in growth failure.
Using the same criterion, however, Bergstrom et a!
[6] and Stickler and Bergen [7] could find no evi-
dence that calorie malnutrition caused growth fail-
ure. The most compelling evidence that poor calorie
intake causes growth failure in uremic children was
presented by Simmons et al [27], who showed that
five dialysis patients with calorie intakes less than
67% of RDA (Recommended Daily Allowance) had
growth rates 34% of normal, whereas seven chil-
dren with calorie intakes greater than 67% of RDA
had growth rates 117% of normal. When calorie
supplements were given to four children with poor
intakes, total calorie intake increased and growth
rates became normal. Arnold et al [28] showed that
growth in uremic children not on dialysis increased
when calorie intakes were increased by the use of
supplements. In a study by Betts and Magrath [1] of
27 children with renal insufficiency, 18 had calorie
intakes below those recommended for children of
the same height; in children with renal disease dat-
ing from infancy, there was a significant correlation
between calorie intake and growth. In a more recent
study, the same group [29], however, showed no in-
crease in growth velocity in 11 children with renal
insufficiency and calorie intakes less than 80% of
RDA when their calorie intakes were increased with
supplements; it was concluded that decreased calo-
rie intake is a related but not casual factor in growth
retardation. A relationship between calorie intake
and growth also could not be established by Broyer
et al [2] in 17 children undergoing dialysis, or by the
London Children's Home Dialysis Group [30] in 24
children.
The relationship of protein intake and protein me-
tabolism to growth in uremic children is more com-
plex and less well defined. Children in developed
countries eat a surfeit of protein and, when total
food consumption is reduced secondary to the ano-
rexia of renal failure, protein intake probably re-
mains adequate in most children. The majority of
children with decreased calorie intake and impaired
growth studied by Simmons et al [27] had adequate
protein intake, as usually defined, as did the chil-
dren in the London Children's Home Dialysis
Group [30], of whom 11 of 18 grew poorly. On the
other hand, 69% of children studied by Betts and
Magrath [1] had intakes below the average recom-
mended for children of similar age, and 17% had in-
takes below minimal protein requirements.
Protein losses during chronic dialysis may in-
crease the protein requirement of children under-
going these procedures. Amino acid and peptide
losses during hemodialysis in adults are approxi-
mately 9 to 12 g [31, 32], whereas losses during pen-
toneal dialysis are somewhat less. Figures for chil-
dren are not available. Protein losses, primarily al-
bumin, during peritoneal dialysis were 9 to 15 g in
three children 10 to 14 yr of age (Potter, unpub-
lished data). Most children undergoing chronic pen-
toneal dialysis in Seattle maintained normal serum
albumin concentrations, however, and their growth
rates were comparable to those reported for chil-
dren on hemodialysis [4].
Abnormalities of protein metabolism as well as
decreased intake may play a role in the malnutri-
tion, muscle-wasting, and impaired linear growth in
many uremic patients. Fürst et al [33] showed that
the incorporation of nitrogen-iS into muscle and
plasma protein increased after a dialysis procedure,
and they suggested that there is an inhibitor of pro-
tein synthesis in uremic serum. A number of inves-
tigators have found abnormal plasma amino acid
patterns in uremic patients; although many of these
abnormalities can be attributed to inadequate pro-
tein intake, when uremic and control patients were
given an adequate diet, abnormalities persisted in
the uremic patients [34] (see also Alvestrand et al,
this issue). Heidland and Kult [35] demonstrated
that adult dialysis patients who were receiving an
apparently adequate amount of calories and protein
had decreased serum protein concentrations char-
acteristic of protein malnutrition. These concentra-
tions turned to normal when the patients were given
i.v. infusions of essential amino acids for 16 weeks.
In the only study of amino acids and growth, how-
ever, Counahan et al [36] could find no correlation
between individual amino acid concentrations and
growth rates in 16 children on chronic dialysis (see
also Kopple; Holliday and Chantler, this issue).
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Summary
Growth retardation occurs in 35 to 65% of chil-
dren with kidney disease. It is especially common in
children with congenital diseases of the kidney,
anomalies, and inherited disorders. Acquired dis-
ease, however, also may impair growth, particu-
larly where renal function (GFR) is below 25
mllminll.73 m2. Therapy used in renal disease, no-
tably prednisone, also impairs growth. Chronic dial-
ysis therapy, both hemodialysis and peritoneal, are
associated with poor growth. Several specific
changes in renal disease are associated with growth
failure. These include, in addition to azotemia, acid-
osis, hyposthenuria, renal osteodystrophy, endo-
crine disorders and resistance to hormone action,
and nutritional disturbances.
Reprint requests to Dr. D. E. Potter, University of California
at San Francisco, Children's Renal Center, 400 Parnassus Ave-
nue, A-276, San Francisco, California 94143, U.S.A.
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